Non-ionizing segment to drive demand for breast imaging market

The breast imaging market is projected to grow from an estimated USD 3.7 billion in 2020 to USD 5.4 billion by 2025, at a CAGR of 8.1 percent, estimates MarketsandMarkets. Market growth is largely driven by factors like technological advancements, the rising prevalence of breast cancer, the increasing number of screening programs as well as rising number of conferences and symposiums, focusing on spreading awareness about the benefits of early screening and diagnosis. The emerging markets, growing government and private investments to meet the increasing demand for breast cancer screening, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players. The non-ionizing breast imaging segment is expected to grow at the highest CAGR during 2020–2025. Growth in this segment can be attributed to the advantages offered by non-ionizing breast imaging technologies over ionizing breast imaging technologies like greater generation of anatomical details for diagnosis, high sensitivity to small breast lesions in women with dense breast tissues, and fewer false positives. Mammography accounted for the largest share of the ionizing breast imaging technologies market in 2019. Its large share can be attributed to technological advancements in this segment and increasing awareness.

The breast ultrasound segment accounted for the largest share of the non-ionizing breast imaging technologies market in 2019 whereas the AWBU segment is estimated to witness the second-highest growth rate during the forecast period. The large share of the breast ultrasound segment can be attributed to the lower risk of exposure to radiation and the benefits offered by breast ultrasound such as the ability to detect lesions and the nature of lesions in women with dense breast tissues, the ability to differentiate between a cyst and a solid mass, and the detection of blood flow through vessels.

Key players operating in the global breast imaging market are Hologic, Inc., GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Fujifilm Holdings Corporation, Canon Inc., Aurora Healthcare US Corp., Allengers, Dilon Technologies, Inc., Planmed Oy, Delphinus Medical Technologies, Inc., Micrima Limited, CMR Naviscan Corporation, SuperSonic Imagine, and Carestream Health among others.